Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisGraft vs Host DiseaseAntigens, CD34MelphalanCombined Modality TherapyBlood Component RemovalGraft SurvivalBusulfanMyeloablative AgonistsStem Cell TransplantationBone Marrow TransplantationMultiple MyelomaCyclophosphamideTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearLymphoma, Non-HodgkinTransplantation ChimeraRecurrenceHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionTissue DonorsCytophagocytosisCarmustineDisease-Free SurvivalIfosfamideHistocompatibilitySalvage TherapyWhole-Body IrradiationVincristineVidarabineAmyloidosisRetrospective StudiesStem CellsHematopoiesisHistocompatibility TestingCytarabineHodgkin DiseaseLeukemiaCord Blood Stem Cell TransplantationImmunosuppressive AgentsSurvival AnalysisNeoplasmsGraft vs Leukemia EffectT-LymphocytesTime FactorsSurvival RateInfectionLymphoma, T-CellDoxorubicinRecombinant ProteinsPlatelet CountPOEMS SyndromeBlood CellsLeukemia, Myeloid, AcuteTransplantation, IsogeneicPrednisoneCarboplatinHLA AntigensBlood Cell CountDexamethasoneFollow-Up StudiesCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsCytomegalovirus InfectionsImmunophenotypingLymphomaFlow CytometryProspective StudiesBone Marrow PurgingFatal OutcomeLymphocytesFeasibility StudiesLymphocyte ActivationCyclosporineAnemia, AplasticMyelodysplastic SyndromesLymphocyte DepletionAntigens, CDCell SeparationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChronic DiseaseBone MarrowTransplantation ImmunologyBlood Transfusion, AutologousLiver TransplantationImmunosuppressionBlood Donors